Importantly, the proapoptotic response in tumor cells upon pharmacological inhibition of NF-κB appeared to be context dependent in Kras-driven NSCLC models (Meylan et al., 2009; Xue et al., 2011), indicating that additional pathways contribute to modulating NF-κB dependences. Here, KRAS is linked to non-small cell lung carcinoma.